The corona pandemic (COVID-19) as a prognostic factor - Is there "COVID upstaging" in patients with head and neck tumors?

The corona pandemic (COVID-19) as a prognostic factor - Is there "COVID upstaging" in patients with head and neck tumors? - CoV-UP

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00024176

Enrollment

100

Registered

2021-03-01

Start date

2021-04-01

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Head and Neck Cancer

Interventions

Group 1: Patients with malignancies of the oral cavity and pharynx, but also patients with malignancies of the skin who present to the tumor board are systematically recorded. By comparing the tumor v

Eligibility

Sex/Gender

All

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: The study population includes all adult patients who presented to the Department of Oral and Maxillofacial Surgery at the University of Leipzig in 2019-2020, including the second pandemic wave (early 2021), due to a new tumor disease or a tumor recurrence. The inclusion criterion is presentation to the head and neck tumor board, the skull base board, or the skin tumor board of Leipzig University Hospital. Thus, patients with malignancies of the oral cavity and pharynx, but also patients with malignancies of the skin were systematically included.

Exclusion criteria

Exclusion criteria: Age less than 18 years, Benign tumors, Basal cell carcinomas, Malignant melanomas, Metastases to head and neck of other tumors, CUP, Isolated lymph node metastases of known tumors.

Design outcomes

Primary

Measure	Time frame
Treatment data of patients with head and neck cancer in maxillofacial surgery in the pandemic period are retrospectively compared with corresponding data of the previous year's period. The inclusion criterion is presentation to the head and neck tumor board, skull base board, or skin tumor board, respectively. Demographic and anamnestic patient data (age, sex, main diagnosis, concomitant diseases, noxae) as well as tumor findings and, if applicable, surgical findings depending on the therapy performed are collected. In addition, the time of initial presentation or diagnosis as well as the start of treatment and the therapy carried out are recorded. In addition to histopathological tumor classification according to the TNM system, digital measurement of pre-therapeutic tumor volumes in staging imaging is provided. The pathological assessment of the maximum tumor extension and the tumor stage thereby allow a comparison with the volume measurement.	—

Measure

Time frame

Treatment data of patients with head and neck cancer in maxillofacial surgery in the pandemic period are retrospectively compared with corresponding data of the previous year's period. The inclusion criterion is presentation to the head and neck tumor board, skull base board, or skin tumor board, respectively. Demographic and anamnestic patient data (age, sex, main diagnosis, concomitant diseases, noxae) as well as tumor findings and, if applicable, surgical findings depending on the therapy performed are collected. In addition, the time of initial presentation or diagnosis as well as the start of treatment and the therapy carried out are recorded. In addition to histopathological tumor classification according to the TNM system, digital measurement of pre-therapeutic tumor volumes in staging imaging is provided. The pathological assessment of the maximum tumor extension and the tumor stage thereby allow a comparison with the volume measurement.

—

Countries

Germany

Contacts

Public ContactBernd Lethaus

Klinik für Mund-, Kiefer- und Plastische Gesichtschirurgie

mkg@medizin.uni-leipzig.de0341 9721100

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026